Figures & data
Figure 1 Figure showing the stages of addition of immunosuppressive agents in treatment of patients with steroid-resistant idiopathic nephrotic syndrome. Abbreviations: CyA: cyclosporin A, Prog: prograf, MMF: mycophenolate mofetil, CTX: cyclophosphamide, PS: pulse steroid.
![Figure 1 Figure showing the stages of addition of immunosuppressive agents in treatment of patients with steroid-resistant idiopathic nephrotic syndrome. Abbreviations: CyA: cyclosporin A, Prog: prograf, MMF: mycophenolate mofetil, CTX: cyclophosphamide, PS: pulse steroid.](/cms/asset/61b87a24-0e04-44c2-9464-5dd37943d41c/irnf_a_119845_uf0001_b.gif)
Table 1. Clinical features and histology of the patients with steroid-resistant minimal change disease and focal segmental glomerulosclerosis (FSGS) treated with a combination of immunosuppressive agents
Table 2. Treatment and response of patients with steroid-resistant minimal change disease and focal segmental glomerulosclerosis treated with a combination of immunosuppressive agents